Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomes

  • Harel Dahari, Evaldo S. Affonso de Araujo, Bart L. Haagmans, Thomas J. Layden, Scott J. Cotler, Antonio A. Barone, Avidan U. Neumann
  • Journal of Hepatology, September 2010, Elsevier
  • DOI: 10.1016/j.jhep.2010.03.019

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.jhep.2010.03.019

The following have contributed to this page: Dr Bart L. Haagmans